Local control with multimodality therapy for Stage 4 neuroblastoma
- 1 March 2000
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 46 (4) , 969-974
- https://doi.org/10.1016/s0360-3016(99)00399-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Metastatic Sites in Stage IV and IVS Neuroblastoma Correlate With Age, Tumor Biology, and SurvivalJournal of Pediatric Hematology/Oncology, 1999
- Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.Journal of Clinical Oncology, 1996
- Stage 4 neuroblastoma diagnosed at more than 1 year of age: Gross total resection and clinical outcomeJournal of Pediatric Surgery, 1994
- Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.Journal of Clinical Oncology, 1993
- Sites of relapse in patients with neuroblastoma following bone marrow transplantation in relation to preparatory “debulking” treatmentsJournal of Pediatric Surgery, 1992
- Dose-intensive use of cyclophosphamide in ablation of neuroblastomaCancer, 1990
- Radiation therapy in the management of neuroblastoma: The Duke University medical center experience 1967–1984International Journal of Radiation Oncology*Biology*Physics, 1986
- Stage IV‐N: A favorable subset of children with metastatic neuroblastomaMedical and Pediatric Oncology, 1985
- Improved survival in neuroblastoma using multimodality therapyRadiotherapy and Oncology, 1984
- Incidence of malignant tumors in U.S. childrenThe Journal of Pediatrics, 1975